PharmaCielo Ltd. (TSXV:PCLO)

Canada flag Canada · Delayed Price · Currency is CAD
0.0550
-0.0050 (-8.33%)
Mar 21, 2025, 2:55 PM EST
-73.17%
Market Cap 10.54M
Revenue (ttm) 3.48M
Net Income (ttm) -9.14M
Shares Out 175.72M
EPS (ttm) -0.05
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 55,044
Average Volume 333,582
Open 0.0600
Previous Close 0.0600
Day's Range 0.0550 - 0.0650
52-Week Range 0.0550 - 0.2900
Beta 2.20
RSI 42.93
Earnings Date May 29, 2025

About PharmaCielo

PharmaCielo Ltd., together with its subsidiary, engages in cultivating, processing, and supplying medicinal-grade cannabis extracts in Canada. Its products include medicinal-grade dried cannabis flower, cannabis oil extracts, tetrahydrocannabinol and cannabidiol medical cannabis, and other cannabis related products, as well as provides telemedicine software. The company also exports its products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies. The company has strategic partnership with B... [Read more]

Sector Healthcare
CEO Marc Lustig
Country Canada
Stock Exchange TSX Venture Exchange
Ticker Symbol PCLO
Full Company Profile

Financial Performance

In 2024, PharmaCielo's revenue was 3.48 million, an increase of 125.70% compared to the previous year's 1.54 million. Losses were -9.14 million, -43.91% less than in 2023.

Financial Statements

News

There is no news available yet.